tiprankstipranks
Holding IT:SELJLB?
Track your performance easily

IT:SELJLB Price & Analysis

SELJLB ETF Chart & Stats

Day’s Range― - ―
52-Week Range€105.22 - €140.27
Previous Close€106.4
VolumeN/A
Average Volume (3M)N/A
AUM365.64K
NAV106.40
Expense Ratio3.36%
Holdings Count28
Beta0.44
Inception DateJan 24, 2011
Next Dividend Ex-DateN/A
Dividend YieldN/A
Shares OutstandingN/A
Standard Deviation0.00
10 Day Avg. Volume0
30 Day Avg. VolumeN/A
Alpha0.00

Selectra Investments SICAV - J. Lamarck Biotech (SELJLB) Fund Flow Chart

Selectra Investments SICAV - J. Lamarck Biotech (SELJLB) 1 year Net Flows: -€42K

SELJLB ETF FAQ

What was IT:SELJLB’s price range in the past 12 months?
IT:SELJLB lowest ETF price was €105.22 and its highest was €140.27 in the past 12 months.
    What is the AUM of IT:SELJLB?
    As of Apr 22, 2024 The AUM of IT:SELJLB is 365.64K.
      Is IT:SELJLB overvalued?
      According to Wall Street analysts IT:SELJLB’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
        Does IT:SELJLB pay dividends?
        IT:SELJLB does not currently pay dividends.
        How many shares outstanding does IT:SELJLB have?
        Currently, no data Available
        Which hedge fund is a major shareholder of IT:SELJLB?
        Currently, no hedge funds are holding shares in IT:SELJLB

        SELJLB ETF Smart Score

        For ETFs, the calculations for the Smart Score, Analyst Consensus, Price Target, Blogger Sentiment, News Sentiment and Insider Transactions are based on the weighted average of the ETF's holdings and some additional factors. Hedge Fund Trend, Crowd Wisdom and Technicals are based on the actual ETF ticker.​

        Top 10 Holdings

        Name
        Weight %
        Biogen Inc.
        8.57%
        Gilead Sciences
        6.13%
        Exelixis
        6.03%
        Ionis Pharmaceuticals Inc.
        5.98%
        Regeneron Pharmaceuticals
        5.52%
        Arvinas Holding Company
        5.04%
        Vertex Pharmaceuticals Inc.
        4.87%
        Crispr Therapeutics
        4.75%
        Amgen Inc
        4.44%
        Incyte
        4.42%
        Total55.74%

        ETF Description

        Selectra Investments SICAV - J. Lamarck Biotech

        The main objective of this Sub-Fund is to profit from increasing share prices in the biotechnology sector. The focus is on mature top tier pharmaceutical biotech companies and companies with interesting pipeline of products in development in a single or numerous markets, like Nasdaq or NYSE.
        Sector
        Sector
        Asset Class
        Equity
        Region
        Global
        Issuer
        Selectra Investments
        Index Tracked
        No Underlying Index
        Ticker Symbol
        IT:SELJLB
        Popular ETFs
        What's Included in PREMIUM?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis